Stephen Arcona

873 total citations
19 papers, 661 citations indexed

About

Stephen Arcona is a scholar working on Psychiatry and Mental health, Surgery and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Stephen Arcona has authored 19 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 4 papers in Surgery and 3 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Stephen Arcona's work include Dementia and Cognitive Impairment Research (3 papers), Schizophrenia research and treatment (3 papers) and Neurological Complications and Syndromes (2 papers). Stephen Arcona is often cited by papers focused on Dementia and Cognitive Impairment Research (3 papers), Schizophrenia research and treatment (3 papers) and Neurological Complications and Syndromes (2 papers). Stephen Arcona collaborates with scholars based in United States, Switzerland and United Kingdom. Stephen Arcona's co-authors include Douglas Gause, Leslie Leahy, Ross J. Baldessarini, John Hennen, Simu K. Thomas, Lee B. Riley, Minlei Liao, Farid Kianifard, Yunfeng Li and Zhang and has published in prestigious journals such as Transplantation, Psychiatric Services and Breast Cancer Research and Treatment.

In The Last Decade

Stephen Arcona

19 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Arcona United States 12 309 132 109 86 85 19 661
Nello Martini Italy 17 119 0.4× 106 0.8× 68 0.6× 52 0.6× 89 1.0× 72 883
Kamel Masmoudi France 18 91 0.3× 67 0.5× 139 1.3× 49 0.6× 68 0.8× 57 791
Giuseppe Roberto Italy 15 162 0.5× 108 0.8× 46 0.4× 57 0.7× 117 1.4× 50 726
L. V. Wilton United Kingdom 15 153 0.5× 78 0.6× 161 1.5× 57 0.7× 31 0.4× 22 816
Hieronymus J. Derijks Netherlands 14 100 0.3× 87 0.7× 77 0.7× 46 0.5× 65 0.8× 47 699
Jonathan L. Halperin United States 4 475 1.5× 145 1.1× 99 0.9× 72 0.8× 21 0.2× 5 1.4k
Lyne Nadeau Canada 15 82 0.3× 99 0.8× 202 1.9× 67 0.8× 51 0.6× 26 878
Todd Williamson United States 17 106 0.3× 184 1.4× 138 1.3× 61 0.7× 27 0.3× 59 1.0k
Emmanuelle Bondon‐Guitton France 17 98 0.3× 51 0.4× 148 1.4× 45 0.5× 54 0.6× 44 834
Elizabeth T. Masters United States 17 148 0.5× 292 2.2× 169 1.6× 27 0.3× 237 2.8× 50 1.0k

Countries citing papers authored by Stephen Arcona

Since Specialization
Citations

This map shows the geographic impact of Stephen Arcona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Arcona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Arcona more than expected).

Fields of papers citing papers by Stephen Arcona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Arcona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Arcona. The network helps show where Stephen Arcona may publish in the future.

Co-authorship network of co-authors of Stephen Arcona

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Arcona. A scholar is included among the top collaborators of Stephen Arcona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Arcona. Stephen Arcona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Slejko, Julia F., J.D. Rueda, Emily Gorman, et al.. (2019). A Comprehensive Review of Methods to Measure Oral Oncolytic Dose Intensity Using Retrospective Data. Journal of Managed Care & Specialty Pharmacy. 25(10). 1125–1132. 3 indexed citations
2.
3.
Yu, Tzy‐Chyi, Huanxue Zhou, Kangho Suh, & Stephen Arcona. (2015). Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease. ClinicoEconomics and Outcomes Research. 7. 37–37. 38 indexed citations
4.
Yawn, Barbara P., et al.. (2013). Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis. International Journal of COPD. 8. 295–295. 74 indexed citations
5.
6.
Cooper, Matthew, Kathleen L. Deering, Douglas P. Slakey, et al.. (2009). Comparing Outcomes Associated With Dose Manipulations of Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Renal Transplant Recipients. Transplantation. 88(4). 514–520. 23 indexed citations
7.
Baldessarini, Ross J., et al.. (2007). Patterns of Psychotropic Drug Prescription for U.S. Patients With Diagnoses of Bipolar Disorders. Psychiatric Services. 58(1). 85–91. 216 indexed citations
8.
Hatoum, Hind T., Swu‐Jane Lin, Stephen Arcona, et al.. (2005). The Use of the Occupational Disruptiveness Scale of the Neuropsychiatric Inventory-Nursing Home Version to Measure the Impact of Rivastigmine on the Disruptive Behavior of Nursing Home Residents With Alzheimer’s Disease. Journal of the American Medical Directors Association. 6(4). 238–245. 13 indexed citations
9.
Suh, Dong‐Churl, Simu K. Thomas, Elmira Valiyeva, Stephen Arcona, & Lien Vo. (2005). Drug Persistency of Two Cholinesterase Inhibitors. Drugs & Aging. 22(8). 695–707. 44 indexed citations
10.
Hughes, Anthony J., et al.. (2004). Gastrointestinal Adverse Events in a General Population Sample of Nursing Home Residents Taking Cholinesterase Inhibitors. The Consultant Pharmacist. 19(8). 713–720. 7 indexed citations
11.
Beusterien, Kathleen, Simu K. Thomas, Douglas Gause, et al.. (2004). Impact of Rivastigmine Use on the Risk of Nursing Home Placement in a US Sample. CNS Drugs. 18(15). 1143–1148. 28 indexed citations
12.
Suh, Dong‐Churl, Stephen Arcona, Simu K. Thomas, et al.. (2004). Risk of Antipsychotic Drug Use in Patients with Alzheimer???s Disease Treated with Rivastigmine. Drugs & Aging. 21(6). 395–403. 22 indexed citations
13.
Belletti, Daniel, Robert Bolash, Stephen Arcona, & James Reed. (2002). Improving Guideline Compliance: Assessment of Unit-Based Reminder for Monitoring Platelet Counts Post-PCI. Journal for Healthcare Quality. 24(1). 9–14. 1 indexed citations
14.
Belletti, Daniel, et al.. (2002). National Prescribing Patterns in the Management of Extrapyramidal Symptoms among Patients with Schizophrenia. The International Journal of Psychiatry in Medicine. 32(3). 261–269. 12 indexed citations
15.
Arcona, Stephen, et al.. (2001). Comparing tympanic membrane and pulmonary artery catheter temperatures. Dimensions of Critical Care Nursing. 20(2). 44–49. 3 indexed citations
16.
Arcona, Stephen, et al.. (2001). Tympanic membrane vs. pulmonary artery thermometry. Nursing Management. 32(6). 42–42. 9 indexed citations
17.
Riley, Lee B., et al.. (2001). The role of sentinel lymph node mapping in staging of colon and rectal cancer. Diseases of the Colon & Rectum. 44(6). 850–854. 77 indexed citations
18.
19.
Arcona, Stephen, et al.. (1956). [Effects of various diets on experimental nephritis in rats].. PubMed. 11(18). 823–34. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nello Martini Breakdown of academic impact, for papers by Kamel Masmoudi Breakdown of academic impact, for papers by Giuseppe Roberto Breakdown of academic impact, for papers by L. V. Wilton Breakdown of academic impact, for papers by Hieronymus J. Derijks Breakdown of academic impact, for papers by Jonathan L. Halperin Breakdown of academic impact, for papers by Lyne Nadeau Breakdown of academic impact, for papers by Todd Williamson Breakdown of academic impact, for papers by Emmanuelle Bondon‐Guitton Breakdown of academic impact, for papers by Elizabeth T. Masters
Rankless by CCL
2026